Paul Bisaro's Net Worth
Estimate Recalculated Nov 1, 2024 08:35AM EST
Who is Paul Bisaro
Paul Bisaro has an estimated net worth of $112 Million. This is based on reported shares across multiple companies, which include ZIMMER HOLDINGS INC, Zoetis Inc., Amneal Pharmaceuticals, Inc., Actavis plc, Mallinckrodt plc, TherapeuticsMD, Inc., MYRIAD GENETICS INC, WATSON PHARMACEUTICALS INC, IMPAX LABORATORIES INC, and BARR PHARMACEUTICALS INC.
SEC CIK
Paul Bisaro's CIK is 0001237253
Past Insider Trading and Trends
2007 was Paul Bisaro's most active year for acquiring shares with 36 total transactions. Paul Bisaro's most active month to acquire stocks was the month of January. 2007 was Paul Bisaro's most active year for disposing of shares, totalling 70 transactions. Paul Bisaro's most active month to dispose stocks was the month of September. 2013 saw Paul Bisaro paying a total of $16,163,952.00 for 1,161,508.319 shares, this is the most they've acquired in one year. In 2013 Paul Bisaro cashed out on 1,595,925 shares for a total of $84,247,187.78, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
